These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26140440)

  • 1. Commercialization of new biotechnology: a systematic review of 16 commercial case studies in a novel manufacturing sector.
    Paul MJ; Thangaraj H; Ma JK
    Plant Biotechnol J; 2015 Oct; 13(8):1209-20. PubMed ID: 26140440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target product selection - where can Molecular Pharming make the difference?
    Paul MJ; Teh AY; Twyman RM; Ma JK
    Curr Pharm Des; 2013; 19(31):5478-85. PubMed ID: 23394563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The next 15 years: taking plant-made vaccines beyond proof of concept.
    Kirk DD; Webb SR
    Immunol Cell Biol; 2005 Jun; 83(3):248-56. PubMed ID: 15877602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Realising the value of plant molecular pharming to benefit the poor in developing countries and emerging economies.
    Ma JK; Christou P; Chikwamba R; Haydon H; Paul M; Ferrer MP; Ramalingam S; Rech E; Rybicki E; Wigdorovitz A; Yang DC; Thangaraj H
    Plant Biotechnol J; 2013 Dec; 11(9):1029-33. PubMed ID: 24119183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commercialization of animal biotechnology.
    Faber DC; Molina JA; Ohlrichs CL; Vander Zwaag DF; Ferré LB
    Theriogenology; 2003 Jan; 59(1):125-38. PubMed ID: 12499024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sticking to the knitting: CIHR, innovation and Canadian biotech.
    Edelson J
    Healthc Q; 2005; 8(3):65-8. PubMed ID: 16078405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The making of an entrepreneurial science: biotechnology in Britain, 1975-1995.
    de Chadarevian S
    Isis; 2011 Dec; 102(4):601-33. PubMed ID: 22448540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marine biotechnologies and synthetic biology, new issues for a fair and equitable profit-sharing commercial use.
    Bloch JF; Tardieu-Guigues E
    Mar Genomics; 2014 Oct; 17():79-83. PubMed ID: 25116370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant plant-derived pharmaceutical proteins: current technical and economic bottlenecks.
    Sabalza M; Christou P; Capell T
    Biotechnol Lett; 2014 Dec; 36(12):2367-79. PubMed ID: 25048244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent patents in plant biotechnology: impact on global health.
    Hefferon KL
    Recent Pat Biotechnol; 2012 Aug; 6(2):97-105. PubMed ID: 22642820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategic Research Institute--first international siRNA conference. Prospect for new therapeutics and commercial opportunities for pharma and biotech. 24-25 March 2003, LaJolla, CA, USA.
    Xu J
    IDrugs; 2003 May; 6(5):449-50. PubMed ID: 12841209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Business Ethics 101 for the biotech industry.
    MacDonald C
    BioDrugs; 2004; 18(2):71-7. PubMed ID: 15046523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Pharming for low and middle income countries.
    Murad S; Fuller S; Menary J; Moore C; Pinneh E; Szeto T; Hitzeroth I; Freire M; Taychakhoonavudh S; Phoolcharoen W; Ma JK
    Curr Opin Biotechnol; 2020 Feb; 61():53-59. PubMed ID: 31751895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manufacturing, regulatory and commercial challenges of biopharmaceuticals production: a Finnish perspective.
    Närhi M; Nordström K
    Eur J Pharm Biopharm; 2005 Apr; 59(3):397-405. PubMed ID: 15760720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Business Models in Funding the Biotech Industry: Global Trends and Challenges for Cuban Biotechnology.
    Blanco-García E
    MEDICC Rev; 2020 Jan; 22(1):11-16. PubMed ID: 32327617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotechnology and research: promise and problems.
    La Montagne JR
    Lancet; 2001 Nov; 358(9294):1723-4. PubMed ID: 11728568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing genomics to improve health in the Eastern Mediterranean Region - an executive course in genomics policy.
    Acharya T; Rab MA; Singer PA; Daar AS
    Health Res Policy Syst; 2005 Jan; 3(1):1. PubMed ID: 15663786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomedical research and the commercialization agenda: a review of main considerations for neuroscience.
    Caulfield T; Ogbogu U
    Account Res; 2008; 15(4):303-20. PubMed ID: 18972268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commercialization of biotechnology in the Asian region. Report of meeting of Asian Productivity Organization (APO) in Osaka, Japan.
    Rogers PL
    Aust J Biotechnol; 1990 Jan; 4(1):18-20. PubMed ID: 1369443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotechnology and the developing world. Finding ways to bridge the agricultural technology gap.
    Platais KW; Collinson MP
    Finance Dev; 1992 Mar; ():34-6. PubMed ID: 12284926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.